Avlaan Pharmaceutical Private Limited

This company deals with buying, selling, and trading pharmaceutical raw materials and medical supplies.

2014 | Chennai, Tamil Nadu (India) | Active
Last Updated:

Avlaan Pharmaceutical Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -50.57%
  • Profit Growth 13.54%
  • Ebitda 118.61%
  • Net Worth 28.47%
  • Total Assets 9.27%

About Avlaan Pharmaceutical

Avlaan Pharmaceutical Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 December 2014 and has a history of Ten years and three months. Its registered office is in Chennai, Tamil Nadu, India.

The Company is engaged in the Chemicals And Materials Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Anurag Lodha and Arun Natarajan serve as directors at the Company.

Company Details

  • Location

    Chennai, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24100TN2014PTC098319

  • Company No.

    098319

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 Dec 2014

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Chemicals and Materials
Pharma
Company report

Avlaan Pharmaceutical Private Limited

Explore comprehensive data for Avlaan Pharmaceutical Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Avlaan Pharmaceutical?

Board Members (2)

NameDesignationAppointment DateStatus
Anurag Lodha Country flag representing Us Director 04-Dec-2014Current
Arun Natarajan Country flag representing Us Director 04-Dec-2014Current

Financial Performance of Avlaan Pharmaceutical.

Avlaan Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.57% decrease. The company also saw a substantial improvement in profitability, with a 13.54% increase in profit. The company's net worth Soared by an impressive increase of 28.47%.

Avlaan Pharmaceutical revenue growth over time
Avlaan Pharmaceutical profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-50.57%
Revenue from Operations
-49.71%
Total Assets
9.27%
Profit or Loss
13.54%
Net Worth
28.47%
EBITDA
118.61%

What is the Ownership and Shareholding Structure of Avlaan Pharmaceutical?

In 2023, Avlaan Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Avlaan Pharmaceutical?

Unlock and access historical data on people associated with Avlaan Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Avlaan Pharmaceutical Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avlaan Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avlaan Pharmaceutical's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Avlaan Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Avlaan Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Avlaan Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

  • Director Appointment

    Anurag Lodha was appointed as a Director was appointed as a Director on 04 Dec 2014 & has been associated with this company since 10 years 3 months .

  • Director Appointment

    Arun Natarajan was appointed as a Director was appointed as a Director on 04 Dec 2014 & has been associated with this company since 10 years 3 months .

  • Company Incorporation

    Avlaan Pharmaceutical Private Limited was registered on 04 Dec 2014 with Roc Chennai & aged 10 years 3 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Avlaan Pharmaceutical Private Limited?

    Avlaan Pharmaceutical Private Limited was incorporated on 04 Dec 2014.

  • What is authorized share capital and paid-up capital of Avlaan Pharmaceutical Private Limited?

    The authorized share capital of Avlaan Pharmaceutical Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Avlaan Pharmaceutical Private Limited?

    Currently 2 directors are associated with Avlaan Pharmaceutical Private Limited.

    • Anurag Lodha
    • Arun Natarajan
  • What is the registered address of Avlaan Pharmaceutical Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Avlaan Pharmaceutical Private Limited is 207 Dbs House 31A Cathedral Garden Road Nungambakkam, India, Chennai, Tamil Nadu, 600034.

  • What is the corporate identification number (CIN) and company number of Avlaan Pharmaceutical Private Limited?

    The corporate identification number (CIN) of Avlaan Pharmaceutical Private Limited is U24100TN2014PTC098319 and the company number is 098319 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Avlaan Pharmaceutical Private Limited?

    The Official website of Avlaan Pharmaceutical Private Limited is https://www.avlaanpharma.com

  • What has been the recent revenue trend for Avlaan Pharmaceutical Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Avlaan Pharmaceutical Private Limited has fallen by -50.57%.

  • What change has been observed in the net worth of Avlaan Pharmaceutical Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Avlaan Pharmaceutical Private Limited has experienced an upsurge of 28.47%.

  • When was the last Balance Sheet of Avlaan Pharmaceutical Private Limited filed with the ROC?

    The most recent Balance Sheet for Avlaan Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial